Chemotherapy Hair Loss MDL Will Be Considered At Sept. 29 Hearing
WASHINGTON, D.C. — Arguments will be heard Sept. 29 on the centralization of federal lawsuits in which breast cancer patients allege that the chemotherapy drug Taxotere causes permanent hair loss, according...To view the full article, register now.
Already a subscriber? Click here to view full article